Showing results (821-830 of 872) with videos related to
Sort By:
Pageof 88
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 15, 2023
Hyperuricemia increases the risk of cardiovascular mortality associated with very high HdL-cholesterol levelPaolo Palatini, Agostino Virdis, Stefano Masi, et al.Frontiers in Cardiovascular Medicine|October 14, 2021
Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) ProjectElisa Russo, Francesca Viazzi, Roberto Pontremoli, et al.European Journal of Preventive Cardiology|February 14, 2021
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acidPaolo Palatini, Gianfranco Parati, Agostino Virdis, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 19, 2021
The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality riskNicola Riccardo Pugliese, Alessandro Mengozzi, Agostino Virdis, et al.Revista Panamericana De Salud Publica = Pan American Journal of Public Health|March 3, 2020
[Lancet Commission on Hypertension Group position statement on the global improvement of accuracy standards for devices that measure blood pressurePosicionamento do Grupo da Lancet Commission on Hypertension sobre a melhoria global dos padrões de acurácia para aparelhos que medem a pressão arterial]James E Sharman, Eoin O'Brien, Bruce Alpert, et al.Journal of Hypertension|December 3, 2019
Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressureJames E Sharman, Eoin O'Brien, Bruce Alpert, et al.Journal of Hypertension|December 1, 2022
Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off valuesEdoardo Casiglia, Valérie Tikhonoff, Agostino Virdis, et al.Journal of Clinical Medicine|January 11, 2024
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with EdoxabanMassimo Mapelli, Irene Mattavelli, Elisabetta Salvioni, et al.International Journal of Cardiology|August 13, 2018
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillationJeness Campodonico, Massimo Piepoli, Francesco Clemenza, et al.European Journal of Preventive Cardiology|September 28, 2014
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillationDamiano Magrì, Piergiuseppe Agostoni, Ugo Corrà, et al.Pageof 88